Tomotherapy

Baptist Health Lexington selects RayStation

Retrieved on: 
Thursday, October 26, 2023
Cyberknife, Tomotherapy, RaySearch Laboratories, Patient, Workflow, Pharmaceutical industry, Accuray, Elekta, Varian

STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- RayStation will be used to treat patients at Baptist Health Lexington as well as Baptist Health Hamburg. It will be used to plan for a wide range of delivery systems, including linear accelerators from Elekta and Varian as well as CyberKnife and Tomotherapy from Accuray. RayStation will also be used for high dose rate brachytherapy planning. The configuration includes advanced features such as fallback planning, multi-criteria optimization, dose tracking and adaptive radiation therapy.

Key Points: 
  • RaySearch Laboratories AB (publ) announces that Baptist Health Lexington, Kentucky, USA, has begun implementation of the treatment planning system RayStation®*.
  • STOCKHOLM, Oct. 26, 2023 /PRNewswire/ -- RayStation will be used to treat patients at Baptist Health Lexington as well as Baptist Health Hamburg.
  • Chris Roty, President, Baptist Health Lexington, says: "We are pleased to be able to implement RayStation in our Baptist System.
  • Right now, RayStation is the only treatment planning system available that can facilitate a unified workflow for such large and diversified centers as Baptist Health Lexington and Baptist Health Hamburg and we are looking forward to a successful collaboration."

Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

Retrieved on: 
Monday, September 18, 2023
Cyberknife, CE, Cancer, Patient, Tomotherapy, Knowledge, Health, Education, Nursing, Accuray

Different education modalities - from in-person at the Accuray facility to on-site and self-paced, remote – enable medical teams to choose when and how they learn.

Key Points: 
  • Different education modalities - from in-person at the Accuray facility to on-site and self-paced, remote – enable medical teams to choose when and how they learn.
  • "Our customers are passionate about improving the lives of people diagnosed with cancer and certain neurologic conditions.
  • Short, convenient education modules developed in response to customer feedback and led by Accuray clinical specialists.
  • A platform for CyberKnife, TomoTherapy and Radixact System users to gain knowledge and build partnerships focused on improving the treatment of cancer and neurologic conditions.

Global Radiation Therapy Market Forecast Report 2023-2027: A $13.28 Billion Market in 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, June 26, 2023
Health, Pharmaceutical, Proton, Urbanization, Hitachi, Ion Beam Applications, Hospital, COVID-19, Ageing, Radiation, IGRT, Radiosurgery, Particle accelerator, Incidence, US, Proton therapy, Growth, IMRT, Medical imaging, Tomotherapy, LINAC

The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast (2023-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast (2023-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The global radiation therapy market is expected to reach US$13.28 billion in 2027, witnessing growth at a CAGR of 6.77%, over the period 2023-2027.
  • The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type.
  • Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy.

SHINE Technologies Appoints Experienced Company Builder to Board of Directors

Retrieved on: 
Wednesday, June 7, 2023
Morgridge Institute for Research, University, Lutetium, MBA, Public health, Tomotherapy, University of Wisconsin School of Medicine and Public Health, Shine Technologies, Anesthesiology, Faculty, Growth, Research, GE HealthCare, SHINE, San Diego State University, Nursing

JANESVILLE, Wis., June 7, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced the appointment of Dr. Frederick Robertson to the company's board of directors.

Key Points: 
  • JANESVILLE, Wis., June 7, 2023 /PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced the appointment of Dr. Frederick Robertson to the company's board of directors.
  • Robertson brings a wealth of experience in building companies in the medical device, life science and pharmaceutical industries.
  • He held the role of CEO and director of TomoTherapy, a producer of sophisticated X-ray-based cancer therapy equipment, until the company was acquired in 2011.
  • "This is an exciting time for SHINE as it works to make fusion-driven medical isotopes a reality," Robertson said.

Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness

Retrieved on: 
Wednesday, May 17, 2023
Pancreatic cancer, Cyberknife, SBRT, Abstract, CE, Deep inspiration breath-hold, SRS, Radiation, Health care, DIBH, Prostate cancer, Metastasis, Cosmesis, Cancer, Quality of life, Lung cancer, Toxicity, MBA, Brain, Prostate, Sale, Movement, Synchrony, Radiation therapy, Motion, LINAC, Patient, Tomotherapy, Breast, Ultra, Accuracy and precision, Neoplasm, European Society for Medical Oncology, Congress, Health, Recurrence, Melphalan, Safety, Pharmaceutical industry, Medical imaging, Medical device, Dairy, Accuray

SUNNYVALE, Calif., May 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife® and TomoTherapy® platforms, including the latest generation Radixact® System. More than 55 abstracts highlighting Accuray technologies were presented at the 2023 ESTRO annual congress held in Vienna, Austria, from May 12 to May 16, 2023, building on existing clinical evidence and supporting the systems' use to deliver (ultra) hypofractionated radiation treatments for the precise and personalized treatment of a wide range of cancers.

Key Points: 
  • During the meeting, Accuray hosted a symposium titled " Advances in Hypofractionation for Breast and Prostate Cancer " featuring clinical experts who discussed the most recent – and promising – clinical studies.
  • "The information sharing that takes place at meetings such as ESTRO is focused on the same critical goal – improving patient care.
  • Delivering ablative doses to target spinal metastases, ensuring good local control and low rates of toxicity while protecting critical organs5.
  • It is not CE marked and availability is subject to regulatory clearance or approval in some markets.

Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022

Retrieved on: 
Monday, November 28, 2022
IMV, History, Field service management, Radiation therapy, Cyberknife, Patient, Education, Radiation, Overalls, Security (finance), Synchrony, Tomotherapy, Engineer, Cancer, Risk, Medical imaging, Science

According to the IMV ServiceTrak Radiation Oncology 2022 report, Accuray achieved the highest score in the industry in Overall Service Performance and was recognized for Best Service in Radiation Oncology.

Key Points: 
  • According to the IMV ServiceTrak Radiation Oncology 2022 report, Accuray achieved the highest score in the industry in Overall Service Performance and was recognized for Best Service in Radiation Oncology.
  • The IMV report includes feedback on radiation therapy technologies used in treating cancer patients in the U.S. and specifically, survey respondents with hands-on experience using Accuray radiation therapy delivery systems.
  • The Accuray Service team is dedicated to ensuring our customers are successful with our products.
  • According to ServiceTrak, Accuray also achieved the highest ratio of customers highly satisfied with Field Service Engineers Overall and top scores in related categories: Service Follow-Up, Field Service Engineer Competence and Timely Phone Response.

Tampa General Hospital Cancer Institute Is Expanding and Now Providing Comprehensive Cancer Treatment Services to the Brandon Area and Surrounding Communities

Retrieved on: 
Wednesday, November 9, 2022
Trauma, Diagnosis, Environment, Cyberknife, Hospital, News, Round Top hospitals, Tower, Physician, Radiation therapy, Neuroscience, Liver, Patient, Forbes, Lymphatic system, Fast Track, Home, Tampa General Hospital, Cancer, TGH, Drink, Brandon, Woman, Intensive care unit, Tomotherapy, Medical examiner, U.S. News & World Report, Interstate Highway System, GE Healthcare, Radiation, Neoplasm, Lee Roy Selmon Expressway, Health, State, Interstate 75, Safety, Technology, Breast, Adult, Medical imaging, Medical device, Tampa Bay

TAMPA, Fla., Nov. 9, 2022 /PRNewswire/ -- Tampa General Hospital (TGH) is expanding services for the rapidly growing communities of south Hillsborough County by adding another TGH Cancer Institute Infusion Center to its patient offerings, with state-of-the-art radiation oncology services to follow. Located in the TGH Brandon Healthplex outpatient medical center at 10740 Palm River Road in Tampa, the newest TGH Cancer Institute Infusion Center will help make infusion treatment and cancer care more accessible and closer to home for patients in the Brandon area and surrounding communities.

Key Points: 
  • TAMPA, Fla., Nov. 9, 2022 /PRNewswire/ -- Tampa General Hospital (TGH) is expanding services for the rapidly growing communities of south Hillsborough County by adding another TGH Cancer Institute Infusion Center to its patient offerings, with state-of-the-art radiation oncology services to follow.
  • Located in the TGH Brandon Healthplex outpatient medical center at 10740 Palm River Road in Tampa, the newest TGH Cancer Institute Infusion Center will help make infusion treatment and cancer care more accessible and closer to home for patients in the Brandon area and surrounding communities.
  • Both expansions are the product of a greater effort to develop a world-class cancer center at Tampa General.
  • The Brandon Healthplex and the TGH Cancer Institute are at 10740 Palm River Road, Tampa, near the Lee Roy Selmon Expressway and Interstate 75.

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

Retrieved on: 
Friday, September 30, 2022
Olive, Hospital, SBRT, YouTube, Risk, Health, Time, Radiation, Twitter, Children's Cancer Hospital Egypt, Neoplasm, Organization, LinkedIn, Tomotherapy, Private Securities Litigation Reform Act, Forward-looking statement, U.S. Securities and Exchange Commission, Patient, Travel, Cancer, CEO, Quality of life, Annual report, NASDAQ, Refer, Cyberknife, Security (finance), SEC, Lists of diseases, SRS, Disease, Medicine, Medical imaging, Child, Facebook

SUNNYVALE, Calif., Sept. 30, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform in Africa, making it possible for more patients to obtain access to the extremely precise stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments the system delivers. The Children's Cancer Hospital 57357 (Hospital 57357) medical care team is the first in Egypt and Africa to treat patients using the system, while the Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) is the second in Africa and first in Kenya to acquire the system.

Key Points: 
  • "We are proud that such esteemed organizations have selected the CyberKnife System to enhance the quality of care they provide their patients.
  • Hospital 57357 continues its legacy of innovation with the installation and treatment of the first patients in Egypt and Africa using the CyberKnife System.
  • "At Children's Cancer Hospital 57357, patients and their families are at the center of everything we do.
  • "In Kenya, cancer is a public health concern and too few people who would benefit from radiation therapy treatments are receiving care.

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

Retrieved on: 
Friday, September 30, 2022
Olive, Hospital, SBRT, YouTube, Risk, Health, Time, Radiation, Twitter, Children's Cancer Hospital Egypt, Neoplasm, Organization, LinkedIn, Tomotherapy, Private Securities Litigation Reform Act, Forward-looking statement, U.S. Securities and Exchange Commission, Patient, Travel, Cancer, CEO, Quality of life, Annual report, NASDAQ, Refer, Cyberknife, Security (finance), SEC, Lists of diseases, SRS, Disease, Medicine, Medical imaging, Child, Facebook

SUNNYVALE, Calif., Sept. 30, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife® platform in Africa, making it possible for more patients to obtain access to the extremely precise stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments the system delivers. The Children's Cancer Hospital 57357 (Hospital 57357) medical care team is the first in Egypt and Africa to treat patients using the system, while the Kenyatta University Teaching, Referral & Research Hospital (KUTRRH) is the second in Africa and first in Kenya to acquire the system.

Key Points: 
  • "We are proud that such esteemed organizations have selected the CyberKnife System to enhance the quality of care they provide their patients.
  • Hospital 57357 continues its legacy of innovation with the installation and treatment of the first patients in Egypt and Africa using the CyberKnife System.
  • "At Children's Cancer Hospital 57357, patients and their families are at the center of everything we do.
  • "In Kenya, cancer is a public health concern and too few people who would benefit from radiation therapy treatments are receiving care.

Acrisure Names Kelly Conway as New Chief Human Resources Officer

Retrieved on: 
Tuesday, June 21, 2022
Professional Services, Data Management, Technology, Insurance, Finance, Software, Perpetual Real Estate Services, Inc. v. Michaelson Properties, Inc., Culture, University of Arizona, Partner, CEO, Company, Entrepreneurship, Northern Arizona University, Leadership, Arc, Growth, Marketing, Capital punishment, Operation, Conway, Human resources, Tomotherapy, Coca-Cola Enterprises, Management, Insurance

Acrisure, a fast-growing fintech leader that operates a top-10 global insurance broker, today announced it has appointed Kelly Conway as the firms new Chief Human Resources Officer.

Key Points: 
  • Acrisure, a fast-growing fintech leader that operates a top-10 global insurance broker, today announced it has appointed Kelly Conway as the firms new Chief Human Resources Officer.
  • Conway joins Acrisure with more than two decades of experience leading global human resources business partner functions as well as talent management, recruitment, training and development.
  • Conway has led global teams in over eleven countries and is excited to bring this expertise to Acrisure.
  • Conway has held positions as director of human resources and talent development at Coca-Cola Enterprises, The Arc of San Francisco and TomoTherapy.